水雾喷雾吸入制剂(ADI)的APSD
ADI的空气动力学粒径分布将决定液滴气溶 胶微细粒子吸入后可能的沉积位置。 如果微细粒子太大, 则会卡在咽喉后部。微细粒子太小, 则被呼出而不是沉积在体内。 多级撞击器是测量ADI产品的APSD 是否满足法规和药典要求的首选仪器, 有五种不同的多级撞击器适合评估APSD, 但美国药典和欧洲药典只提及了安德 生多级撞击器(ACI), 新一代撞击器(NGI)和多级液体撞击器 (MSLI)。
相关应用程序
我们还提供一系列额外的对软雾吸入(吸入喷雾剂)测试应用支持设备:
级联撞击器是怎样运作?
播放视频相关新闻与资源
Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing
14th September 2022
了解更多的详情
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
22nd June 2021
了解更多的详情
Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley
18th March 2021
了解更多的详情
Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
1st March 2021
了解更多的详情
Confused about cascade impaction? Watch the new animations from Copley Scientific to improve your understanding of inhaled drug product testing.
22nd August 2016
了解更多的详情
New, state-of-the-art vision system central to Copley Scientific’s cascade impactor validation service
24th July 2007
了解更多的详情
Q&A: OINDPnews 2022
检视下载
DDD 2021 Respiratory eBook Profile
检视下载
PMPS Q&A (Samedan): April 2021
检视下载
ONdrugDelivery Article: November 2020
检视下载
Inhalation Article: December 2019
检视下载
Inhalation Article: April 2019
检视下载
ONdrugDelivery Article: December 2018
检视下载
Drug Development & Delivery Article: April 2018
检视下载
PMPS Article (Samedan): February 2018
检视下载
White Paper: February 2018
检视下载